Study pinpoints means to restore the efficacy of drugs for acute myeloid leukemia
AZO Life Sciences,
Researchers from Johns Hopkins Kimmel Cancer Center in their recent research elucidate why certain drugs, in clinical trials…
Researchers from Johns Hopkins Kimmel Cancer Center in their recent research elucidate why certain drugs, in clinical trials…
【字体: 大 中 小 】 时间:2021年09月29日 来源:Johns Hopkins Medicine 编辑推荐: 新的研究表明,为什么一些治疗急性髓系白血病(AML)的临床试验药物常常失败,并证明了一种恢复疗效的方法。 这项临床前研究发表在9月的《Bl…
New research from Johns Hopkins Kimmel Cancer Center investigators shows why some drugs in clinical trials for treating a form…
New research from Johns Hopkins Kimmel Cancer Center investigators shows why some drugs in clinical trials for treating a form…
New research from Johns Hopkins Kimmel Cancer Center investigators shows why some drugs in clinical trials for treating a form…
New research from Johns Hopkins Kimmel Cancer Center investigators shows why some drugs in clinical trials for treating a form…
New research shows why some drugs in clinical trials for treating a form of acute myeloid leukemia (AML) often fail and…
New research from Johns Hopkins Kimmel Cancer Center investigators shows why some drugs in clinical trials for treating a form…
New research from Johns Hopkins Kimmel Cancer Center investigators shows why some drugs in clinical trials for treating a form…
Credit: CC0 Public Domain New research from Johns Hopkins Kimmel Cancer Center investigators shows why some drugs in clinical…
Johns Hopkins Medicine 2,800 compounds from the Johns Hopkins Drug Library were screened for the ability to restore the…
Newswise — New research from Johns Hopkins Kimmel Cancer Center investigators shows why some drugs in clinical trials for…